Reveromycin B – 1 mg

Brand:
Cayman
CAS:
144860-68-4
Storage:
-20
UN-No:
Non-Hazardous - /

Reveromycin B is a spiroketal bacterial metabolite originally isolated from Streptomyces.{28254} It inhibits EGF-induced mitogenic activity in Balb/MK cells (IC50 = 6 μg/ml) and exhibits pH-dependent antifungal activity against C. albicans (MICs = 15.6 and >500 μg/ml at pH 3.0 and 7.4, respectively). Unlike reveromycin A (Item No. 17458) and reveromycin C (Item No. 23488), reveromycin B does not inhibit proliferation of KB and K562 cells.  

 

Available on backorder

SKU: 25481 - 1 mg Category:

Description

A bacterial metabolite; inhibits EGF-induced mitogenic activity in Balb/MK cells (IC50 = 6 μg/ml); exhibits pH-dependent antifungal activity against C. albicans (MICs = 15.6 and >500 μg/ml at pH 3.0 and 7.4, respectively),


Formal name: butanedioic acid, 1-[(1S,2E,4E)-1-[(2R,5S,7R,8S)-2-butyl-7-[(2E,4E,6S,7S,8E)-9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrien-1-yl]-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-5-carboxy-4-methyl-2,4-pentadien-1-yl] ester

Synonyms: 

Molecular weight: 660.8

CAS: 144860-68-4

Purity: ≥98%

Formulation: A lyophilisate


Product Type|Biochemicals|Antifungals||Product Type|Biochemicals|Natural Products|Microbial Metabolites||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Fungal Diseases|Candidiasis